RxDoctor Payments Data

Lori Cordial, MD

Family Medicine · Rural Hall, NCNPI 1588855944

Payments from drug & device makers

$1,512in general payments, 2019–2025

Across 85 payments — averaging $17.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$230
  • Pfizer$153
  • Astellas Pharma US Inc$140
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$116
  • Ironwood Pharmaceuticals, Inc$110
  • AbbVie$106
  • plus $658 from 17 others

What the payments were for

  • Speaking & faculty fees$201%
  • Food & beverage$1,33488%
  • Education$1007%
  • Gifts$584%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,512 in reported general payments places this provider in the 75th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$36,101
Medicare patients
91
Services billed
367

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban96$91,026
JanuviaSitagliptin Phosphate24$25,672
FarxigaDapagliflozin Propanediol24$19,911
MyrbetriqMirabegron30$18,963
XareltoRivaroxaban23$17,256
JardianceEmpagliflozin20$13,802
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$11,453
SymbicortBudesonide/Formoterol Fumarate17$8,703
Omeprazole250$5,476
Albuterol Sulfate HfaAlbuterol Sulfate139$3,991
Lantus SolostarInsulin Glargine,hum.Rec.Anlog36$3,686
Levothyroxine Sodium319$2,865
Losartan Potassium244$2,344
Ventolin HfaAlbuterol Sulfate37$2,207
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate13$2,077

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$153$91,02696 claims
AstraZenecaFarxiga, Symbicort$230$28,61441 claims
Astellas Pharma US IncMyrbetriq$140$18,96330 claims
Boehringer IngelheimJardiance$95$13,80220 claims
GSKTrelegy Ellipta$51$11,45314 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Rural Hall

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →